HEADER TRANSFERASE 20-MAR-06 2GET TITLE PANTOTHENATE KINASE FROM MYCOBACTERIUM TUBERCULOSIS (MTPANK) IN TITLE 2 COMPLEX WITH A COENZYME A DERIVATIVE, FORM-I (LT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANTOTHENATE KINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PANK, PANTOTHENIC ACID KINASE; COMPND 5 EC: 2.7.1.33; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: H37RV; SOURCE 5 GENE: COAA(RV1092C); SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28A(+) (NOVAGEN) KEYWDS HOMODIMER, COA BIOSYNTHESIS, NUCLEOTIDE BINDING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN REVDAT 6 20-NOV-24 2GET 1 REMARK REVDAT 5 25-OCT-23 2GET 1 REMARK SEQADV LINK REVDAT 4 18-OCT-17 2GET 1 REMARK REVDAT 3 13-JUL-11 2GET 1 VERSN REVDAT 2 24-FEB-09 2GET 1 VERSN REVDAT 1 06-JUN-06 2GET 0 JRNL AUTH S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN JRNL TITL INVARIANCE AND VARIABILITY IN BACTERIAL PANK: A STUDY BASED JRNL TITL 2 ON THE CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 62 628 2006 JRNL REFN ISSN 0907-4449 JRNL PMID 16699190 JRNL DOI 10.1107/S0907444906012728 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN REMARK 1 TITL EXPRESSION, PURIFICATION, CRYSTALLIZATION AND PRELIMINARY REMARK 1 TITL 2 X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PANTOTHENATE KINASE FROM REMARK 1 TITL 3 MYCOBACTERIUM TUBERCULOSIS REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 61 65 2005 REMARK 1 REFN ESSN 1744-3091 REMARK 1 PMID 16508093 REMARK 1 DOI 10.1107/S1744309104028040 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1203414.530 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 16654 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 817 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.43 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1519 REMARK 3 BIN R VALUE (WORKING SET) : 0.3820 REMARK 3 BIN FREE R VALUE : 0.4750 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 91 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2483 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 175 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.55000 REMARK 3 B22 (A**2) : 2.40000 REMARK 3 B33 (A**2) : -1.85000 REMARK 3 B12 (A**2) : 3.23000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.41 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.55 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.510 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.540 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.850 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 66.20 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP+CME.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : DRGCNS_COA_2ME+GLY.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN+CME.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MLF FUNCTION THROUGHOUT THE REFINEMENT REMARK 4 REMARK 4 2GET COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000037029. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JAN-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU ULTRAX 18 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16654 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 28.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 9.900 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.56200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ID 1ESM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-15%(W/V) PEG8000, 0.05M NACL, 0.05 REMARK 280 -0.1M NAOAC IN 0.1M NA-CACODYLATE BUFFER OF PH 6.5, 0.001M BETA- REMARK 280 MERCAPTOETHANOL WAS PRESENT IN THE PROTEIN BUFFER, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.88233 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 75.76467 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 75.76467 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 37.88233 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE FOLLOWING SYMMETRY OPERATION WILL GENERATE THE SECOND REMARK 300 SUBUNIT OF THE HOMODIMERIC MTPANK MOLECULE: SYMMETRY:Y, X, -Z; REMARK 300 TRANSSYMM: 556 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 7680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 113.64700 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 LEU A 4 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 83 CG CD OE1 NE2 REMARK 470 ASN A 84 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 23 -132.77 60.11 REMARK 500 THR A 25 106.93 -27.27 REMARK 500 LEU A 40 109.97 -52.87 REMARK 500 GLN A 43 52.28 -96.85 REMARK 500 GLN A 82 42.43 -109.95 REMARK 500 GLN A 83 168.42 -36.82 REMARK 500 ASN A 84 -172.21 49.42 REMARK 500 ASP A 86 95.85 -26.55 REMARK 500 HIS A 120 81.25 40.01 REMARK 500 HIS A 194 66.65 30.15 REMARK 500 THR A 245 -114.05 -132.17 REMARK 500 ALA A 248 -56.73 -12.90 REMARK 500 HIS A 253 1.85 -61.24 REMARK 500 HIS A 256 -3.30 -54.09 REMARK 500 ILE A 276 -60.88 -128.44 REMARK 500 HIS A 302 -5.03 73.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE COK A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GES RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-I (RT) REMARK 900 RELATED ID: 2GEU RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-II REMARK 900 (RT) REMARK 900 RELATED ID: 2GEV RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-II REMARK 900 (LT) DBREF 2GET A 1 312 UNP P63810 COAA_MYCTU 1 312 SEQADV 2GET CME A 173 UNP P63810 CYS 173 MODIFIED RESIDUE SEQRES 1 A 312 MET SER ARG LEU SER GLU PRO SER PRO TYR VAL GLU PHE SEQRES 2 A 312 ASP ARG ARG GLN TRP ARG ALA LEU ARG MET SER THR PRO SEQRES 3 A 312 LEU ALA LEU THR GLU GLU GLU LEU VAL GLY LEU ARG GLY SEQRES 4 A 312 LEU GLY GLU GLN ILE ASP LEU LEU GLU VAL GLU GLU VAL SEQRES 5 A 312 TYR LEU PRO LEU ALA ARG LEU ILE HIS LEU GLN VAL ALA SEQRES 6 A 312 ALA ARG GLN ARG LEU PHE ALA ALA THR ALA GLU PHE LEU SEQRES 7 A 312 GLY GLU PRO GLN GLN ASN PRO ASP ARG PRO VAL PRO PHE SEQRES 8 A 312 ILE ILE GLY VAL ALA GLY SER VAL ALA VAL GLY LYS SER SEQRES 9 A 312 THR THR ALA ARG VAL LEU GLN ALA LEU LEU ALA ARG TRP SEQRES 10 A 312 ASP HIS HIS PRO ARG VAL ASP LEU VAL THR THR ASP GLY SEQRES 11 A 312 PHE LEU TYR PRO ASN ALA GLU LEU GLN ARG ARG ASN LEU SEQRES 12 A 312 MET HIS ARG LYS GLY PHE PRO GLU SER TYR ASN ARG ARG SEQRES 13 A 312 ALA LEU MET ARG PHE VAL THR SER VAL LYS SER GLY SER SEQRES 14 A 312 ASP TYR ALA CME ALA PRO VAL TYR SER HIS LEU HIS TYR SEQRES 15 A 312 ASP ILE ILE PRO GLY ALA GLU GLN VAL VAL ARG HIS PRO SEQRES 16 A 312 ASP ILE LEU ILE LEU GLU GLY LEU ASN VAL LEU GLN THR SEQRES 17 A 312 GLY PRO THR LEU MET VAL SER ASP LEU PHE ASP PHE SER SEQRES 18 A 312 LEU TYR VAL ASP ALA ARG ILE GLU ASP ILE GLU GLN TRP SEQRES 19 A 312 TYR VAL SER ARG PHE LEU ALA MET ARG THR THR ALA PHE SEQRES 20 A 312 ALA ASP PRO GLU SER HIS PHE HIS HIS TYR ALA ALA PHE SEQRES 21 A 312 SER ASP SER GLN ALA VAL VAL ALA ALA ARG GLU ILE TRP SEQRES 22 A 312 ARG THR ILE ASN ARG PRO ASN LEU VAL GLU ASN ILE LEU SEQRES 23 A 312 PRO THR ARG PRO ARG ALA THR LEU VAL LEU ARG LYS ASP SEQRES 24 A 312 ALA ASP HIS SER ILE ASN ARG LEU ARG LEU ARG LYS LEU MODRES 2GET CME A 173 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 173 10 HET COK A 401 52 HET GOL A 800 6 HET GOL A 801 6 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM COK [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3- HETNAM 2 COK (PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL (3R)-3- HETNAM 3 COK HYDROXY-4-{[3-({2-[(2-HYDROXYETHYL) HETNAM 4 COK DITHIO]ETHYL}AMINO)-3-OXOPROPYL]AMINO}-2,2-DIMETHYL-4- HETNAM 5 COK OXOBUTYL DIHYDROGEN DIPHOSPHATE HETNAM GOL GLYCEROL HETSYN COK S-(THIOETHYLHYDROXY)COENZYME A HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 COK C23 H40 N7 O17 P3 S2 FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 HOH *175(H2 O) HELIX 1 1 ARG A 15 ARG A 19 1 5 HELIX 2 2 ALA A 20 MET A 23 5 4 HELIX 3 3 THR A 30 GLY A 36 1 7 HELIX 4 4 ASP A 45 VAL A 52 1 8 HELIX 5 5 VAL A 52 LEU A 78 1 27 HELIX 6 6 GLY A 102 ARG A 116 1 15 HELIX 7 7 ASP A 129 LEU A 132 5 4 HELIX 8 8 PRO A 134 ARG A 140 1 7 HELIX 9 9 LEU A 143 LYS A 147 5 5 HELIX 10 10 PHE A 149 TYR A 153 5 5 HELIX 11 11 ASN A 154 GLY A 168 1 15 HELIX 12 12 MET A 213 PHE A 218 5 6 HELIX 13 13 ARG A 227 THR A 244 1 18 HELIX 14 14 PHE A 254 ALA A 258 5 5 HELIX 15 15 SER A 261 ILE A 276 1 16 HELIX 16 16 ILE A 276 ASN A 284 1 9 HELIX 17 17 ILE A 285 ALA A 292 5 8 SHEET 1 A 7 TYR A 10 ASP A 14 0 SHEET 2 A 7 ILE A 304 ARG A 310 -1 O LEU A 307 N PHE A 13 SHEET 3 A 7 LEU A 294 LYS A 298 -1 N VAL A 295 O ARG A 308 SHEET 4 A 7 PHE A 220 ASP A 225 1 N ASP A 225 O LEU A 296 SHEET 5 A 7 PHE A 91 GLY A 97 1 N GLY A 94 O LEU A 222 SHEET 6 A 7 ILE A 197 GLU A 201 1 O LEU A 200 N ILE A 93 SHEET 7 A 7 VAL A 123 THR A 127 1 N VAL A 126 O ILE A 199 SHEET 1 B 2 ALA A 172 SER A 178 0 SHEET 2 B 2 ASP A 183 VAL A 192 -1 O GLN A 190 N ALA A 174 LINK C ALA A 172 N CME A 173 1555 1555 1.33 LINK C CME A 173 N ALA A 174 1555 1555 1.30 SITE 1 AC1 22 GLY A 39 LEU A 40 VAL A 99 ALA A 100 SITE 2 AC1 22 LYS A 103 SER A 104 ARG A 108 LYS A 147 SITE 3 AC1 22 HIS A 179 TYR A 182 TYR A 235 ARG A 238 SITE 4 AC1 22 PHE A 239 MET A 242 PHE A 254 ILE A 272 SITE 5 AC1 22 ILE A 276 ASN A 277 HOH A 552 HOH A 571 SITE 6 AC1 22 HOH A 609 HOH A 637 SITE 1 AC2 3 LEU A 286 PRO A 287 ARG A 289 SITE 1 AC3 6 PHE A 218 SER A 221 ARG A 291 THR A 293 SITE 2 AC3 6 ARG A 310 HOH A 634 CRYST1 76.973 76.973 113.647 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012992 0.007501 0.000000 0.00000 SCALE2 0.000000 0.015001 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008799 0.00000